TSE:PREV Stock Latest News
Company AnnouncementsPreveCeutical Raises $156,000 in First Tranche of Private Placement1w ago
Company AnnouncementsPreveCeutical Launches $600,000 Private Placement to Fund R&D and Corporate Costs1M ago
Company AnnouncementsPreveCeutical Shifts to Semi-Annual Reporting Under CSE Pilot Program7M ago
Company AnnouncementsPreveCeutical Adds Veteran Clinical Leader Raj S. Pruthi to Board to Drive Pipeline Advancement7M ago
Company AnnouncementsPreveCeutical-Backed BioGene Therapeutics Names Raj Pruthi to Board to Drive Gene Therapy Strategy7M ago
Company AnnouncementsPreveCeutical Wins Key Canadian Patent Allowance for Next‑Generation Pain Therapy8M agoCompany AnnouncementsPreveCeutical Files Patent for Direct Brain Delivery of Dopamine and CNS Drugs8M ago
Company AnnouncementsPreveCeutical Finalizes Arrangement with BioGene to Expand Market Reach11M ago
Company AnnouncementsPreveCeutical Clarifies Shareholder Arrangement with BioGene11M ago
Company AnnouncementsPreveCeutical Completes Second Tranche of Private Placement1y ago- Company AnnouncementsPreveCeutical Completes Strategic Arrangement with BioGene1y ago
Company AnnouncementsPreveCeutical Expands Financing and Approves Key Resolutions at Annual Meeting1y ago- Company AnnouncementsPreveCeutical Announces Spin-Out of BioGene Shares to Shareholders1y ago
- Company AnnouncementsPreveCeutical Reschedules Meeting and Announces Director Resignation1y ago
Company AnnouncementsPreveCeutical Medical’s Subsidiary Appoints New CTO to Boost Innovative Therapies1y ago- Company AnnouncementsBioGene Therapeutics Appoints Dr. Kamal Albarazanji to Boost Metabolic Research1y ago
Company AnnouncementsPreveCeutical Reschedules Meeting and Announces Private Placement1y agoCompany AnnouncementsPreveCeutical Appoints Dr. Francis Tavares as CTO to Enhance Drug Discovery Efforts1y ago
Company AnnouncementsPreveCeutical Schedules Annual Meeting and Announces Strategic Share Distribution1y ago
